Why the study?
Does systemic thrombolytic therapy improve outcomes in patients with acute myocardial infarction?
Population
Patients with acute myocardial infarction
Design
Editorial
Authors
Loading...
The rationale for thrombolytic therapy in acute MI is based on the ability of agents like streptokinase or urokinase to reopen occluded coronary arteries and potentially improve clinical outcomes.
Does systemic thrombolytic therapy improve outcomes in patients with acute myocardial infarction?
The rationale for thrombolytic therapy in acute MI is based on the ability of agents like streptokinase or urokinase to reopen occluded coronary arteries and potentially improve clinical outcomes.
Collen et al. (1983) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: